These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18393784)

  • 21. Randomization in clinical studies.
    Lim CY; In J
    Korean J Anesthesiol; 2019 Jun; 72(3):221-232. PubMed ID: 30929415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals.
    Schulz KF; Chalmers I; Grimes DA; Altman DG
    JAMA; 1994 Jul; 272(2):125-8. PubMed ID: 8015122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodological reporting quality of randomized controlled trials: A survey of seven core journals of orthopaedics from Mainland China over 5 years following the CONSORT statement.
    Zhang J; Chen X; Zhu Q; Cui J; Cao L; Su J
    Orthop Traumatol Surg Res; 2016 Nov; 102(7):933-938. PubMed ID: 27514437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjunctival autograft for pterygium.
    Clearfield E; Muthappan V; Wang X; Kuo IC
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.
    Mathieu E; Herbert RD; McGeechan K; Herbert JJ; Barratt AL
    J Clin Epidemiol; 2014 Jun; 67(6):667-71. PubMed ID: 24767518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of randomization techniques for clinical trials with data from the HOMERUS-trial.
    Verberk WJ; Kroon AA; Kessels AG; Nelemans PJ; Van Ree JW; Lenders JW; Thien T; Bakx JC; Van Montfrans GA; Smit AJ; Beltman FW; De Leeuw PW
    Blood Press; 2005; 14(5):306-14. PubMed ID: 16257877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomization and allocation concealment: a practical guide for researchers.
    Doig GS; Simpson F
    J Crit Care; 2005 Jun; 20(2):187-91; discussion 191-3. PubMed ID: 16139163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to randomize.
    Vickers AJ
    J Soc Integr Oncol; 2006; 4(4):194-8. PubMed ID: 17022927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction.
    Hills RK; Gray R; Wheatley K
    J Evid Based Med; 2009 Aug; 2(3):196-204. PubMed ID: 21349013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical trials in orthopedic and trauma surgery: randomized or non-randomized?].
    Stengel D; Bauwens K; Ekkernkamp A
    Unfallchirurg; 2003 Apr; 106(4):294-9. PubMed ID: 12719849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial.
    Sismanidis C; Moulton LH; Ayles H; Fielding K; Schaap A; Beyers N; Bond G; Godfrey-Faussett P; Hayes R
    Clin Trials; 2008; 5(4):316-27. PubMed ID: 18697846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studywise minimization: a treatment allocation method that improves balance among treatment groups and makes allocation unpredictable.
    Perry M; Faes M; Reelick MF; Olde Rikkert MG; Borm GF
    J Clin Epidemiol; 2010 Oct; 63(10):1118-22. PubMed ID: 20304606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulation of various randomization strategies for a clinical trial in sickle cell disease.
    Meurer WJ; Connor JT; Glassberg J
    Hematology; 2016 May; 21(4):241-7. PubMed ID: 26868369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allocation concealment in randomised trials: defending against deciphering.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9306):614-8. PubMed ID: 11867132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical considerations in the intent-to-treat principle.
    Lachin JM
    Control Clin Trials; 2000 Jun; 21(3):167-89. PubMed ID: 10822117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. African HIV/AIDS trials are more likely to report adequate allocation concealment and random generation than North American trials.
    Siegfried N; Clarke M; Volmink J; Van der Merwe L
    PLoS One; 2008; 3(10):e3491. PubMed ID: 18941523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does random participant assignment cause fewer benefits in research participants? Systematic review of partially randomized acupuncture trials.
    Koog YH; Min BI
    J Altern Complement Med; 2009 Oct; 15(10):1107-13. PubMed ID: 19848547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimizing imbalances on patient characteristics between treatment groups in randomized trials using classification tree analysis.
    Linden A; Yarnold PR
    J Eval Clin Pract; 2017 Dec; 23(6):1309-1315. PubMed ID: 28675602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.